Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-14

Clinical Trial Update: Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction [Phase 3]

View source ↗

Summary

Phase 3 trial update on Artefill for correcting moderate to severe atrophic acne scars; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artefill

Snippet

Sponsor: Suneva Medical, Inc. | Conditions: Atrophic Acne Scar | Phase 3 | Status: COMPLETED | Results posted: 2017-02-14